Literature DB >> 29031534

Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway.

Shiying Wang1, Xinxin Zhao1, Suxia Yang1, Baoping Chen1, Jun Shi2.   

Abstract

Diabetic nephropathy (DN) is a metabolic disease characterized by mesangial cell proliferation and extracellular matrix (ECM) accumulation. Salidroside (SAL) is the major ingredient in Rhodiola rosea and possesses beneficial effects on DN. This study aimed to evaluate the effect of SAL on high glucose (HG)-induced oxidative stress and ECM accumulation and the underlying mechanism. Rat glomerular mesangial cells HBZY-1 were induced by high glucose (HG) in the presence or absence of SAL. Cell proliferation was measured by CCK-8 assay. The reactive oxygen species (ROS) level, malondialdehyde (MDA) level and superoxide dismutase (SOD) activity were detected to evaluate oxidative stress. The expression levels of ECM proteins including fibronectin (FN) and type IV collagen (Coll IV) were detected by qRT-PCR and western blot analysis. The expressions of thioredoxin-interacting protein (TXNIP), nod-like receptor protein 3 (NLRP3), apoptosis-associated speck-like protein containing CARD (ASC), and caspase-1 were assessed by western blot. Si-TXNIP or si-NC was transfected into HBZY-1 cells to inhibit TXNIP-NLRP3 inflammasome pathway. The results showed that SAL treatment alleviated HG-induced cell proliferation. SAL reduced the levels of ROS and MDA, and induced the SOD activity. Besides, the mRNA and protein expressions of FN and Coll IV were decreased by SAL. The expression levels of TXNIP, NLRP3, ASC, and caspase-1 were reduced in the SAL treated cells. In addition, TXNIP knockdown inhibited TXNIP-NLRP3 inflammasome activation and suppressed HG-induced cell proliferation, oxidative stress, and ECM accumulation. In conclusion, SAL alleviated HG-induced oxidative stress and ECM accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Diabetic nephropathy; Extracellular matrix accumulation; Oxidative stress; Salidroside; TXNIP inflammasome

Mesh:

Substances:

Year:  2017        PMID: 29031534     DOI: 10.1016/j.cbi.2017.10.012

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  21 in total

1.  Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis.

Authors:  Sha-Sha Xing; Jin Yang; Wen-Jing Li; Jian Li; Lin Chen; Yu-Ting Yang; Xia Lei; Jun Li; Kai Wang; Xun Liu
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

2.  Salidroside alleviates high-glucose-induced injury in retinal pigment epithelial cell line ARPE-19 by down-regulation of miR-138.

Authors:  Cheng Qian; Shenzhi Liang; Guangming Wan; Yi Dong; Taiying Lu; Panshi Yan
Journal:  RNA Biol       Date:  2019-07-11       Impact factor: 4.652

Review 3.  Beneficial Effects of Rhodiola and Salidroside in Diabetes: Potential Role of AMP-Activated Protein Kinase.

Authors:  Tao Zheng; Fang Bian; Li Chen; Qibin Wang; Si Jin
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

4.  Silencing of soluble epoxide hydrolase 2 gene reduces H2O2-induced oxidative damage in rat intestinal epithelial IEC-6 cells via activating PI3K/Akt/GSK3β signaling pathway.

Authors:  Jun Li; Jihui Luo; Yang Zhang; Chunming Tang; Jiang Wang; Chaowu Chen
Journal:  Cytotechnology       Date:  2020-01-06       Impact factor: 2.058

Review 5.  Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.

Authors:  Sandra Rayego-Mateos; José Luis Morgado-Pascual; Lucas Opazo-Ríos; Melania Guerrero-Hue; Cristina García-Caballero; Cristina Vázquez-Carballo; Sebastián Mas; Ana Belén Sanz; Carmen Herencia; Sergio Mezzano; Carmen Gómez-Guerrero; Juan Antonio Moreno; Jesús Egido
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

Review 6.  Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease.

Authors:  Denisa Margină; Anca Ungurianu; Carmen Purdel; George Mihai Nițulescu; Dimitris Tsoukalas; Evangelia Sarandi; Maria Thanasoula; Tatyana I Burykina; Fotis Tekos; Aleksandra Buha; Dragana Nikitovic; Demetrios Kouretas; Aristidis Michael Tsatsakis
Journal:  Food Chem Toxicol       Date:  2020-07-05       Impact factor: 6.023

7.  WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling.

Authors:  Xiaoyu Zhou; Zheng Liu; Ke Ying; Huimin Wang; Peng Liu; Xuefei Ji; Tianyan Chi; Libo Zou; Shaojie Wang; Zhonggui He
Journal:  Oxid Med Cell Longev       Date:  2020-05-30       Impact factor: 6.543

Review 8.  NLRP3 Inflammasome in Metabolic-Associated Kidney Diseases: An Update.

Authors:  Wei Xiong; Xian-Fang Meng; Chun Zhang
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

Review 9.  Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook.

Authors:  Naila Qayyum; Muhammad Haseeb; Moon Suk Kim; Sangdun Choi
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

10.  Astilbin Inhibits High Glucose-Induced Inflammation and Extracellular Matrix Accumulation by Suppressing the TLR4/MyD88/NF-κB Pathway in Rat Glomerular Mesangial Cells.

Authors:  Fang Chen; Xiaoguang Zhu; Zhiqiang Sun; Yali Ma
Journal:  Front Pharmacol       Date:  2018-10-18       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.